NCLAT: Patent Act prevails over Competition Act; CCI can’t probe alleged abuse in patented drug licensing
Nov 03, 2025
|
Simply Register/Sign In to access the free content across the portals!
Not subscribed yet?
Gain access to unlimited paid content by subscribing to our portals